Loading...
Please wait, while we are loading the content...
Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Novohradsky, Vojtech Zamora, Ana Gandioso, Albert Brabec, Viktor Ruiz, José Marchán, Vicente |
| Copyright Year | 2017 |
| Abstract | A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminescent cyclometalated iridium(iii) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated. |
| Starting Page | 5523 |
| Ending Page | 5526 |
| Page Count | 4 |
| File Format | PDF HTM / HTML |
| DOI | 10.1039/c7cc01946g |
| Alternate Webpage(s) | https://pubs.rsc.org/en/Content/ArticlePDF/2017/CC/C7CC01946G |
| Alternate Webpage(s) | http://diposit.ub.edu/dspace/bitstream/2445/113562/1/671086.pdf |
| Alternate Webpage(s) | http://www.rsc.org/suppdata/c7/cc/c7cc01946g/c7cc01946g1.pdf |
| PubMed reference number | 28466888 |
| Alternate Webpage(s) | https://doi.org/10.1039/c7cc01946g |
| Journal | Medline |
| Volume Number | 53 |
| Issue Number | 40 |
| Journal | Chemical communications |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |